<--- Back to Details
First PageDocument Content
Health / Viruses / Experimental cancer treatments / Poxviruses / JX-594 / B-cell chronic lymphocytic leukemia / Oncolytic virus / DNA vaccination / Cancer vaccine / Medicine / Vaccination / Biology
Date: 2013-12-31 13:21:48
Health
Viruses
Experimental cancer treatments
Poxviruses
JX-594
B-cell chronic lymphocytic leukemia
Oncolytic virus
DNA vaccination
Cancer vaccine
Medicine
Vaccination
Biology

GTSAB REPORT Recombinant DNA Advisory Committee

Add to Reading List

Source URL: osp.od.nih.gov

Download Document from Source Website

File Size: 91,17 KB

Share Document on Facebook

Similar Documents

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. Founded 1999, Clague Hodgson, Ph.D. Chief Scientific Officer, VP, R&D, Jim Williams, Ph.D. (200

DocID: 1uuzW - View Document

Biology / Molecular biology / Biochemistry / Chemistry / Gene delivery / DNA / Boehringer Ingelheim / DNA vaccination / Plasmid / Boehringer / Agarose gel electrophoresis / Alkaline lysis

Microsoft PowerPoint - Flyer pDNA

DocID: 1qqYL - View Document

Medicine / Microbiology / Clinical medicine / Ebola / Vaccines / Vaccination / Animal virology / Biological weapons / Ebola virus / DNA vaccination / Immunogenicity / Virus

Microsoft Word - jiu511.doc

DocID: 1qpVj - View Document

Zoonoses / Biological weapons / Tropical diseases / Animal virology / Ebola / Ebola virus / Marburg virus disease / Vaccine / DNA vaccination / Virus / Marburg virus / Vaccinia

SUPPLEMENT ARTICLE Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection

DocID: 1pCnO - View Document

Pioneering the Development of Safe and Effective Non-Viral Vectors and Processes for Human Gene Therapy and DNA Vaccination. • Founded 1999, Clague Hodgson, Ph.D. • Chief Scientific Officer, VP, R&D, Jim Williams, Ph

DocID: 1jJjX - View Document